Page 45 - 《中国药科大学学报》2026年第2期
P. 45

第  57 卷第  2 期                  张欣艺,等:胰脂肪酶抑制剂筛选方法的研究进展                                      171

                    high-resolution  inhibition  profiling[J].  Phytochem  Anal,  2024,  screening,  synthesis  and  biological  evaluation[J].  Phytochem
                    35(3): 540-551.                                  Lett, 2022, 51: 28-33.
               [28]   Cheng SP, Yin FC, Wang ZX, et al. A biosensor method based  [35]   Zhai YG, Wang KS, Yu ZH, et al. Pancreatic lipase inhibitors:
                    on  surfactant-mediated surface  droplet  evaporation  for  the   de-  virtual screening and mechanistic analysis[J]. Int J Biol Macro-
                    tection of Aflatoxin B 1 [J]. Food Chem, 2024, 453: 139635.  mol, 2025, 310(Pt 2): 143128.
               [29]   Mu CY, Khan M, Liu JP, et al. Development of surface droplet  [36]   Adivarekar  SS,  Udugade  BV,  Biraje  TM,  et  al.  Repurposing
                    evaporation-based sensing  platform  for  screening  lipase   in-  orlistatanaloges: a ligand-based screening approach using mor-
                    hibitors[J]. Microchem J, 2024, 205: 111256.     gan fingerprints for novel therapeutic agents for obesity[J]. Res
               [30]   Nakai M, Fukui Y, Asami S, et al. Inhibitory effects of oolong  J Pharm Technol, 2025: 3051-3056.
                    tea  polyphenols  on  pancreatic  lipase  in  vitro[J].  J  Agric  Food  [37]   Veeramachaneni  GK,  Raj  KK,  Chalasani  LM,  et  al.  Shape
                    Chem, 2005, 53(11): 4593-4598.                   based virtual screening and molecular docking towards design-
               [31]   Wang  B,  Meng  YY,  Luo  MP,  et  al.  Advancements  in  virtual  ing novel pancreatic lipase inhibitors[J]. Bioinformation, 2015,
                    screening  techniques  for  study  of  enzyme  inhibitor  11(12): 535-542.
                    compounds[J].  China  J  Chin  Mater  Med  (中国中药杂志),  [38]   Citriniti EL, Rocca R, Sciacca C, et al. Leveraging natural com-
                    2023, 48(24): 6533-6544.                         pounds for pancreatic lipase inhibition via virtual screening[J].
               [32]   Zheng XD, Wang S, Fan XY, et al. Virtual screening and activi-  Pharmaceuticals (Basel), 2025, 18(9): 1246.
                    ty  validation  of  natural  pancreatic  lipase  inhibitors[J].  J  Food  [39]   Modanwal  S,  Maurya  AK,  Mishra  SK,  et  al.  Development  of
                    Sci Biotechnol (食品与生物技术学报), 2024, 43(8): 160-172.  QSAR  model  using  machine  learning  and  molecular  docking
               [33]   Wang  B,  Meng  YY,  Luo  MP,  et  al.  Advancements  in  virtual  study of polyphenol derivatives against obesity as pancreatic li-
                    screening  techniques  for  study  of  enzyme  inhibitor  pase  inhibitor[J].  J  Biomol  Struct  Dyn,  2023,  41(14):  6569-
                    compounds[J].  China  J  Chin  Mater  Med  (中国中药杂志),  6580.
                    2023, 48(24): 6533-6544.                    [40]   Yuan YT, Pan F, Zhu ZH, et al. Construction of a QSAR mod-
               [34]   Nguyen L C, Le T T A, Dang T N, et al. Natural mimetic 4-ben-  el based  on  flavonoids  and  screening  of  natural  pancreatic   li-
                    zyloxychalcones  as  potent  pancreatic  lipase  inhibitors:  virtual  pase inhibitors[J]. Nutrients, 2023, 15(15): 3489.
   40   41   42   43   44   45   46   47   48   49   50